Skip to contentK
Kraig Biocraft Laboratories, Inc.
K
KBLBKraig Biocraft Laboratories, Inc. Q1 2018 · 10-Q
Revenue$108.63K$108.63K— vs Q1 2017 Net Income-$278.93K-$278.93KN/M vs Q1 2017 EPS Diluted$0.00$0.00— vs Q1 2017 Operating Income-$226,558N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Kraig Biocraft Laboratories, Inc. · CIK 1413119 · Engraved from SEC EDGAR
Free Cash Flowderived-$84,627N/M Margins · derivedOperating margin-208.6%
Net margin-256.8%
ended Mar 31, 2018 · filed May 11, 2018 · 41 d after period end